What's in Merz Pharmaceuticals GmbH's pipeline?

Merz Pharmaceuticals GmbH has 7 drugs in our index: 2 marketed, 0 filed, 3 in Phase 3, 2 in Phase 2, 0 in Phase 1.

Which companies overlap with Merz Pharmaceuticals GmbH's portfolio?

Top competitors by shared drug class: Allergan, Hexsel Dermatology Clinic, University of Pennsylvania, Daewoong Pharmaceutical Co. LTD., Beth Israel Deaconess Medical Center.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/merz-pharmaceuticals-gmbh.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

Merz Pharmaceuticals GmbH — Portfolio Competitive Intelligence Brief

Merz Pharmaceuticals GmbH pipeline: 2 marketed, 0 filed, 3 Phase 3, 2 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

2 marketed 0 filed 3 Phase 3 2 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
Hyaluronic acid filler/IMD1 basic	Hyaluronic acid filler/IMD1 basic	marketed	Dermal filler		Dermatology/Aesthetics
Contractubex	Contractubex	marketed			Other
incobotulinumtoxinA (Xeomin)	incobotulinumtoxinA (Xeomin)	phase 3	botulinum toxin	SNAP-25	Neurology
IncobotulinumtoxinA (75 Units)	IncobotulinumtoxinA (75 Units)	phase 3	Botulinum toxin	SNAP-25 (synaptosome-associated protein of 25 kDa)	Neurology, Dermatology, Aesthetics
OnabotulinumtoxinA (Vistabel®)	OnabotulinumtoxinA (Vistabel®)	phase 3	botulinum toxin	acetylcholine release	Neurology

Therapeutic area mix

Neurology · 2
Other · 2
Dermatology/Aesthetics · 1
Neurology, Dermatology, Aesthetics · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Allergan · 2 shared drug classes
Hexsel Dermatology Clinic · 2 shared drug classes
University of Pennsylvania · 2 shared drug classes
Daewoong Pharmaceutical Co. LTD. · 1 shared drug class
Beth Israel Deaconess Medical Center · 1 shared drug class
EuBiologics Co.,Ltd · 1 shared drug class
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau · 1 shared drug class
Amir Moradi MD, MBA · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Merz Pharmaceuticals GmbH:

Cite this brief

Drug Landscape (2026). Merz Pharmaceuticals GmbH — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/merz-pharmaceuticals-gmbh. Accessed 2026-05-16.